O. Gaemperli, T. Schepis, P. Koepfli
Jan 22, 2008
Citations
0
Influential Citations
45
Citations
Quality indicators
Journal
Journal of the American College of Cardiology
Abstract
To the Editor: Regadenoson is a selective A2A adenosine receptor agonist under investigation as a pharmacologic vasodilator in nuclear stress myocardial perfusion imaging (MPI) ([1][1]). It has a higher affinity for A2A receptors than adenosine and is a more potent coronary vasodilator. It